MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2020

    Higher grey matter aging in multiple system atrophy than Parkinson’s disease

    M.C Kuo, C.L Chen, C.H Tai, W.Y Tseng, R.M Wu (Taipei, Taiwan)

    Objective: To investigate the “brain age” signature in multiple system atrophy (MSA) and Parkinson's disease (PD), and its correlation with motor and cognitive performance. Background:…
  • MDS Virtual Congress 2020

    Neuroprotective effects of allicin microemulsion against intrastriatal rotenone and manganese induced Parkinsonism in rats

    S. Singh (Moga, India)

    Objective: Allicin is flavonoid that possess neuroprotective potential but main impediment is its low bioavailability which was improved with microemulsion. The present study was framed…
  • MDS Virtual Congress 2020

    Paroxysmal Kinesigenic Dyskinesia: Case series from Çukurova University, Turkey

    M. Demirkiran, M. Balal, A. Bisgin, S. Bozdogan (Adana, Turkey)

    Objective: To present the demographic, clinical and genetic data of ten patients with paroxysmal kinesigenic dyskinesia (PKD). Background: PKD is a rare movement disorder triggered…
  • MDS Virtual Congress 2020

    Stiff person syndrome and acethylcoline receptors ganglionic neuronal antibodies

    J. Lester, J. Cojab, E. Klériga (Huixquilucan, Mexico)

    Objective: Describe a case of stiff person syndrome and positivity for acetylcholine receptors ganglionic neuronal antibodies, not reportes before in stiff person syndrome. Background: Acetylcholine…
  • MDS Virtual Congress 2020

    Substantianigral involvement on Tc99mDaTSPECT-a novel and under recognised imaging finding in Parkinsonian Disorders

    S. Siddiqui, C. Nagaraj, J. Saini, P. Singh, R. Yadav, P. Pal (Bengaluru, India)

    Objective: To assess feasibility of identifying SN involvement on DaTi, correlate with laterality of motor symptoms and compare with loss of nigrosome-1 hyperintensity on SWI . Background:…
  • MDS Virtual Congress 2020

    Racial and Geographic Disparities in Parkinson’s Disease Patients with Gastrostomy Feeding Tube Placement

    D. Kim, Z. Kunicki, R. Jones, A. D'Abreu, J. Friedman, U. Akbar (Providence, RI, USA)

    Objective: We sought to analyze a national database to examine how rates of gastrostomy tube (GT) placement in Parkinson's disease (PD) differ by race and…
  • MDS Virtual Congress 2020

    Identifying Neuropsychiatric Profiles in Parkinson’s disease, Dementia with Lewy Bodies and Alzheimer’s disease

    D. Smith, P. Donaghy, B. Galna, A. Yarnall, J.P Taylor, D. Burn, A. Thomas, L. Rochester, R. Mc Ardle, R. Lawson (Newcastle upon Tyne, United Kingdom)

    Objective: To compare Neuropsychiatric symptoms (NPS) in participants with Parkinson’s disease (PD), Parkinson’s disease with dementia (PDD), dementia with Lewy bodies (DLB), Alzheimer’s disease (AD)…
  • MDS Virtual Congress 2020

    Anxiety disorders are associated with verbal memory impairment in Parkinson’s disease

    N. Dissanayaka, E. Forbes, J. Yang, J. O'Sullivan, D. Copland, K. McMahon, L. Mitchell, G. Byrne (Brisbane, Australia)

    Objective: The present study aimed to investigate the association between anxiety disorders and memory impairment in Parkinson’s disease.The present study aimed to investigate the association…
  • MDS Virtual Congress 2020

    Behavioral and Psychological Symptoms in Patients with Movement Disorders

    M. Kulsum, S. Anand, H. Kumar (Kolkata,, India)

    Objective: To find out the prevalence of neuropsychiatric symptoms in patients with Movement Disorders. To find out the relationship between cognitive impairment and neuropsychiatric symptoms…
  • MDS Virtual Congress 2020

    Parkinson’s Disease Clinical Subtypes: Symptom Progression, Dementia, and Mortality

    P. Myers, J. Jackson, A. Clover, C. Lessov-Schlaggar, E. Foster, J. Perlmutter, M. Campbell (St. Louis, MO, USA)

    Objective: Identify Parkinson's disease (PD) clinical subtypes using multi-domain classification; determine subtype symptom progression; assess subtype clinical utility. Background: People with PD present with combinations…
  • « Previous Page
  • 1
  • …
  • 50
  • 51
  • 52
  • 53
  • 54
  • …
  • 149
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley